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Genome-metabolism interactions enable cell growth.
To probe the extent of these interactions and delin-
eate their functional contributions, we quantified
the Saccharomyces amino acid metabolome and
its response to systematic gene deletion. Over
one-third of coding genes, in particular those impor-
tant for chromatin dynamics, translation, and trans-
port, contribute to biosynthetic metabolism. Specific
amino acid signatures characterize genes of similar
function. This enabled us to exploit functional metab-
olomics to connect metabolic regulators to their ef-
fectors, as exemplified by TORC1, whose inhibition
in exponentially growing cells is shown to match an
interruption in endomembrane transport. Providing
orthogonal information compared to physical and ge-
netic interaction networks, metabolomic signatures
cluster more than half of the so far uncharacterized
yeast genes and provide functional annotation for
them. A major part of coding genes is therefore
participating in gene-metabolism interactions that
expose the metabolism regulatory network and
enable access to an underexplored space in gene
function.
INTRODUCTION
Metabolic alterations play a key role in cancer, metabolic
disease, pathogen infections, microbial communities, caloric
restriction, and driving the aging process. Consequently,
conserved metabolic regulators and sensors, including the
target of rapamycin (TOR) pathway, have regained focus in
medicine and biotechnology (Cornu et al., 2013). However, in
the early days of molecular biology, the metabolic network
was regularly regarded as a static, chemical ‘‘housekeeping’’
network (Wolstenholme and O’Connor, 1959). Metabolism
consequently received limited attention in the context of gene
regulatory networks, and many experiments in yeast and other
organisms have been conducted under supplemented growth
conditions that render large parts of biosynthetic metabolism ar-
tificially dispensable (Gibney et al., 2013; Mu¨lleder et al., 2012).Cell 167, 553–565, Oc
This is an open access article undFor these reasons, the genome-scale picture of the regulation
of biosynthesis and the interactions between genome and me-
tabolome is so far incomplete.
Accounting for a major fraction of the metabolic flux and up to
three-quarters of the total mass of polar metabolites, amino acid
biosynthesis, homeostasis, and catabolism constitute a quanti-
tatively dominating component of the metabolic network (Nissen
et al., 1997; Park et al., 2016). Amino acids serve as precur-
sors for protein synthesis and as intermediates in nucleotide,
cofactor, and lipid synthesis, carbon and nitrogen sensing and
homeostasis, and redox buffering (Ljungdahl and Daignan-For-
nier, 2012). To enable functional genomic approaches to study
their metabolism, we and others have recently repaired amino
acid auxotrophies in a Saccharomyces cerevisiae genome-scale
knockout collection (Winzeler et al., 1999) that facilitates cell
growth in the absence of amino acid supplements (Gibney
et al., 2013; Mu¨lleder et al., 2012). We here exploit targeted me-
tabolomics to record precise amino acid concentration profiles
for all of the strains and assemble the obtained information in a
genome-scale gene-metabolism interaction map. By picturing
themetabolic impact of transcription and signaling that operates
predominantly at the chromatin level or via homeostatic feed-
back by metabolism-dependent systems, the ribosome, or pro-
tein transport, we achieve global insight into the regulation and
homeostasis of metabolism during cell growth.
Gene deletions impact the amino acid metabolome with an
unanticipated precision. This renders the absolute quantitative
amino acid signatures informative about gene function, as they
cluster genetic and pharmacological perturbations according
to functional similarity on the genomic scale. We find that func-
tional metabolomics provides orthogonal information in compar-
ison to existing functional genomic data, in particular compared
to physical and genetic interaction networks, and is found to be a
rich resource to annotate so far uncharacterized genes.
RESULTS
Gene Deletions that Impact the Biosynthetic
Metabolome
4,913 gene-deletion strains that are viable in the absence of
amino acid supplements (Figure S1A; Mu¨lleder et al., 2012)
were cultivated in synthetic minimal medium and grown to expo-
nential phase, and their amino acid profile was determined by a
precise, targeted analysis (Figure 1A). Glutaminewas found to betober 6, 2016 ª 2016 The Author(s). Published by Elsevier Inc. 553
er the CC BY license (http://creativecommons.org/licenses/by/4.0/).
CULTIVATION
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Figure 1. Genome-Metabolome Interactions that Affect Amino Acid Biosynthetic Metabolism
(A) Amino acid quantification in a genome-scale collection of Saccharomyces gene deletion strains, grown inminimal synthetic medium, harvested in exponential
phase (mean ± SD, nt0 = 92, nt8 = 83), and processed by hydrophilic interaction liquid chromatography (LC) selective reaction monitoring (SRM) for the precise
quantification of amino acids. Middle: representative SRM chromatogram (scaled). Bottom: 95% of viable deletion strains (99% of strains growing in minimal
medium) were successfully analyzed; 32% possess a significantly changed metabolome.
(B) Amino acid concentrations span over three orders of magnitude and are affected by gene deletions between 6% and 36%.
(C) Amino acid concentrations are sensitive for up to 373 gene deletions per metabolite.
(D) 1,519 gene deletions significantly affect the amino acid profile as identified by multivariate statistics (c2-test, adjusted p value < 0.01, 1,459 deletion strains)
and univariate statistics (Z-test, adjusted p value < 0.01, 1,069 deletion strains).
(E) Amino acid signatures are predominantly specific, expressed as simultaneously changing amino acid concentrations (bar chart) and as cumulative percentage
(insert). 75% of metabolic profiles are characterized by two or fewer concomitant changes.
(F) Examples of quantitatively high and uniquely specific gene-metabolite interactions.
(G) Duplicated genes specialize in metabolic function. 161 out of 173 genes in homology clusters (53 out of 58 metabolic genes) trigger qualitatively different
metabolic signatures.the highest concentrated amino acid, being three orders of
magnitude more abundant than the lowest concentrated amino
acid, tryptophan (Figure 1B). The average amino acid concen-
tration was sensitive to 163 gene deletions (median, Z-test,
adjusted p value < 0.01), with alanine most frequently (431)
and leucine least frequently affected (25) (Figure 1C). A com-
bined multivariate (c2-test based on robustly estimated Mahala-
nobis distance, adjusted p value < 0.01) and univariate statistic
(Z-test, adjusted p value < 0.01) identified a total of 1,519
(32%) genes of significant impact (Figure 1D). The individual554 Cell 167, 553–565, October 6, 2016amino acid responded by 6%–34% in terms of relative SD (Fig-
ure 1B). The concentration of amino acids did not correlate with
their variability (Figure S1G), with arginine being the most vari-
able (34%) and serine (7%), threonine (6%), valine (6%), and
isoleucine (6%) the most concentration stable (Figure 1B).
Amino acid signatures were not a consequence of growth rate
(Figure S1I), as the average amino acid profile of slow- and fast-
growing strains corresponded largely to that of an average strain
(Figure S1J) and only a weak correlation of growth rate and indi-
vidual concentrations was detected (absolute Spearman’s rank
correlation coefficient < 0.15; Figure S1K). However, several of
the 5%most slow-growing strains (Breslow et al., 2008; Vander-
Sluis et al., 2014) possessed altered amino acid signatures (Fig-
ure S1H). Changes in amino acid metabolism caused by gene
deletion hence manifest upstream of the growth rate.
Indeed, amino acid signatures were highly gene specific. 455
profiles were characterized by a single concentration change,
while only 378 (25%)were characterized bymore than two amino
acid changes (Figure 1E). As extreme cases of specificity, we
detect a genome-wide unique accumulation of glycine in the
absence of the mitochondrial glycine decarboxylase subunits
GCV1 andGCV2, of methionine upon deletion of the S-adenosyl-
methionine synthetases SAM1 and SAM2, of glutamine in yeast
lacking the transcriptional regulator URE2, and of threonine in
the absence of its feedback regulator, FPR1 (Figure 1F).
The metabolic signatures of genes grouped according to
sequence homology (Kuepfer et al., 2005) revealed metabolic
specialization of typical paralogs. In 173 cases, solely one pa-
ralog altered amino acids, followed by 20 cases where each
paralog created a specific signature. At least one amino acid
was commonly affected in only 12 cases. Specialization is
observed for all genes, as well as the subset of metabolic en-
zymes (Figure 1G).
General Transcriptional Control and Protein Transport
Have the Strongest Metabolic Impact
Genes functioning in transcription, chromatin biology, transla-
tion, protein transport, and mitochondrial biology were found
to be responsible for most amino acid concentration changes
in an analysis for Gene Ontology (GO) slim terms (Figure 2A).
As these groups constitute large gene classes, we continued
to test for specific enrichments in a gene set enrichment analysis
(GSEA) (Va¨remo et al., 2013) based on GO term associations
stored in the Saccharomyces genome database (Cherry et al.,
2012). 523 of 6,806 GO functional categories were significant
enriched (adjusted p value < 0.05; Table S1). 80 directly associ-
ated GO terms were assembled in a metabolic ‘‘perturbation
network,’’ which connects the terms according to genes that
overlap (Figure 2A). Genes participating in ‘‘translation,’’ ‘‘protein
and vesicle transport,’’ ‘‘amino acid biosynthesis,’’ the ‘‘mito-
chondrion,’’ ‘‘ribosome biogenesis,’’ and ‘‘transcription/chro-
matin remodeling’’ alter metabolic profiles most frequently
(Figures 2B and S2; Table S1). The network reveals a close asso-
ciation of amino acid biosynthesis and chromatin remodeling
(Figure 2B). This is in contrast to gene-specific transcription fac-
tors (TFs) (Kemmeren et al., 2014) that were not enriched in this
analysis and found to create smaller perturbations in a direct
comparison (Figures 2C and 2D). Ranking of all gene deletions
according to their metabolic impact highlights the dominating
role of histone modifications and the implicated protein
machinery (SWI/SNF [SWItch/Sucrose Non-Fermentable], RSC
[remodel the structure of chromatin], INO80, SAGA [Spt-Ada-
Gcn5-acetyltransferase], and SAGA-like as well as the mediator,
Cdc73/PAF1, and elongator complexes) (Figure 2D). Only intra-
cellular transport had a comparably strong metabolic impact.
This process is required for the recycling of amino acid by pro-
tein degradation and their intracellular transport. The strongest
profiles are triggered by Golgi associated retrograde protein(GARP), Golgi to ER traffic (GET), and endosomal sorting com-
plex required for transport (ESCRT) complexes important for
trafficking, class C core vacuole/endosome tethering (CORVET)
and SNARE proteins important vesicle fusion, as well as the
PIKfyve/ArPIKfyve/Sac3 (PAS) complex required for phosphati-
dylinositol 3-phosphate synthesis (Figure 2E).
The TORC1 Network, but Not the TOR1 Kinase,
Dominates Metabolic Signaling under Exponential
Growth
On the genomic scale, threonine, alanine, serine, and valine
change independently to other metabolites (Figure 3A), but the
remaining amino acids could be assigned to groups that reflect
shared biological properties. Correlated amino acids originate
from a common precursor (e.g., branched chain or aromatic
amino acids), share chemical similarity and function as nitrogen
sensors and donors (glutamine, glutamate), or share their
principal storage compartment, such as the positively charged
arginine, histidine, and lysine. Furthermore, branched-chain
and aromatic amino acids, which share with the Ehrlich pathway
the same catabolic system, were correlated (Figure 3A).
Indicative of co-regulation through the shared pathways,
we addressed the function of transcription factors and kinases.
Despite not being enriched as a GO category (Figure 3), 8% of
altered metabolic signatures are attributed to the deletion of in-
dividual signaling kinases (51), phosphatases (11), and transcrip-
tion factors (62) (Z-test, adjusted p value < 0.01). While many
amino acids were dependent on both signaling and transcription
factors, tryptophan was almost exclusively affected by tran-
scriptional regulators, while two-thirds of genes affecting
glutamate levels were kinases and phosphatases (Figure 3B;
Table S2). Both transcriptional regulation and post-transcrip-
tional regulation are hence important to maintain the amino
acid metabolome, but their relative contribution differs between
metabolites.
TFs, kinases, and phosphatases were then ranked to identify
the most severe perturbations, which confirmed the importance
of chromatin remodeling (SPT10, SNF2, UME6, and ADA2) (Fig-
ure 3C) and highlighted the importance of sensing nitrogen
(GLN3), phosphate (PHO85, PHO80, PHO2, VIP1, and ADK1),
and iron (AFT1), as well as the regulation of carbohydrate and en-
ergy metabolism (GCR2,HAP5, and ELM1). Of note, some of the
key transcriptional regulators active under starvation and stress
were only of moderate importance under the exponential
growth conditions studied. This includes the unfolded protein
response (UPR), the Ssy1p-Ptr3p-Ssy5p (SPS)-sensor systems,
and GCN4 of the general amino acid control (GAAC) pathway,
which under nutrient limitation affects all amino acid pathways
except cysteine (Natarajan et al., 2001) (Figure 3D).
A similar result was obtained for the TOR1 kinase. Despite the
deletion of TOR1 causes a strong amino acid signature under
starvation (Zhang et al., 2011), under exponential growth, its
metabolic impact was not significant. However, in a network
analysis, TORC1 signaling was significantly overrepresented
(Figure 3D). Deletion of the TORC1 subunit TCO89, the down-
stream kinases SCH9 and subunits SIT4 and SAP155 of the
PP2A-related protein phosphatase complex, NPR1, and the
transcription factor SFP1 (Conrad et al., 2014; Loewith andCell 167, 553–565, October 6, 2016 555
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Figure 2. Chromatin and Intracellular Transport Dominate Strong Metabolic Signatures
(A) Top 15 Gene Ontology (GO) slim categories of gene deletions affecting the biosynthetic metabolome.
(B) Functional ‘‘perturbation network’’ constructed on the basis of a gene set enrichment analysis (GSEA). Each node represents an enriched GO term (adjusted
p value < 0.05), which is connected when the gene overlap is >50%. Edges are drawn for shortest paths of one or two; distinct groups were identified by clustering
of the edge betweenness. BP, biological process; MF, molecular function; CC, cellular component. A fully labeled version is given in Figure S2.
(C) Chromatin- and histone-modifying proteins, as part of the general gene expression machinery, have a significantly stronger impact than gene-specific
transcription factors (Wilcoxon rank-sum test).
(D) Protein complexes associated with general transcriptional control at the chromatin level trigger strong metabolic signatures (4,678: most similar to wild-type;
1: most different to wild-type).
(E) Protein complexes associated with vesicle-mediated transport processes that are responsible for strong metabolic signatures (4,678: most similar to wild-
type; 1: most different to wild-type).Hall, 2011) (Figure 3C), all triggered strong and characteristic
amino acid signatures. The metabolic signatures attribute
particular importance to metabolic signaling kinases, which, as
exemplified by FAB1 that generates phosphatidylinositol 3,5-bi-
sphosphate (Yamamoto et al., 1995), were characterized by
stronger profiles as protein kinases (Figure 3C).556 Cell 167, 553–565, October 6, 2016The Metabolic Signature Connects the Dominating
TORC1 Function to Endomembrane Transport
We treated yeast with rapamycin to inhibit TORC1 pharmacolog-
ically and obtained a strongly altered amino acid signature, char-
acterized by an increase in alanine, aspartate, asparagine, gluta-
mate, glutamine, branched-chain amino acids, and aromatic
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Figure 3. Amino Acid Concentrations Correlate on the Genomic Scale and Depend on Genetic Components of the Transcriptional and
Posttranscriptional Regulatory Machinery
(A) Correlation analysis of amino acid levels, color-coded according to biosynthetic precursor (illustrated in B).
(B) Amino acid biosynthetic pathways, colored according to the origin of their carbon backbone. Superimposed are the regulatory mutants that significantly
alter the concentrations (adjusted p < 0.01). Pie charts indicate the relative contribution of TFs, kinases, and phosphatases; the size is scaled to total numbers
(Table S2).
(C) Transcriptional and phospho-signaling mutants ranked by broadest metabolic impact (R3), defined by simultaneously changing metabolites (adjusted p <
0.01).
(D) General regulatory networks and cellular processes tested for enrichment (GSEA).
Abbreviations: PPP, pentose phosphate pathway; TCA, tricarboxylic acid cycle; g6p, glucose 6-phosphate; 3pt, 3-phosphotrioses; 3pg, 3-phosphoglycerate;
pep, phosphoenolpyruvate; oaa, oxaloacetate; glo, glyoxylate; akg, a-keto-glutarate; amino acids in three letter code; *p < 0.05, **p < 0.01, ***p < 0.001,
Benjamini-Hochberg (BH) adjusted.amino acids as well as reduction in glycine, serine, and lysine
(Figures 4A and S3).Wemapped this profile to the genome-scale
data and identified theDtco89 profile to be of close resemblance
(Figure 4A; Data S1, hierarchical cluster analysis). Revealing
the metabolic signature to be a direct consequence of TORC1
inhibition, rapamycin treatment marginally further changed the
profile of the Dtco89 strain (Figure 4B).
We corroborated the metabolic effects by perturbation of
TORC1 activating proteins. This includes the exit from G0 (EGO)
complex (EGO1, EGO2, EGO3, and GTR1) and the GTPase
activating proteins for Gtr2p (LST4/LST7) (Figure 4B). Also, the
absence of other activators, such as the Seh1-associated acti-
vating TORC1 signaling (SEACAT) complex, the type 2A phos-
phatase scaffoldproteinTPD3 (Sutter et al., 2013), or theactivator
PIB2 (Kim and Cunningham, 2015) resulted in a matching signa-
ture (Figure 4B). Conversely, the deletion of NPR3 of the Seh1-
associated complex TORC1-inhibiting (SEACIT) complex (Ne-
klesa and Davis, 2009) mirrored the metabolic profile (Figure 4B).
Hence, the perturbation of TOR upstream activators mimics the
metabolic signatures of rapamycin and TCO89 deletion, while
the deletion of inhibitors causes opposing metabolic defects.Next, we exploited the metabolic signatures to identify the
causative downstream processes. The metabolic signature
of the major TORC1 effector pathways through SCH9 (Urban
et al., 2007) and type 2A and type 2A-related phosphatases (Du¨-
vel et al., 2003) and the inhibition of translation with cyclohexi-
mide did not match the metabolic profile of TORC1 inhibition
(Figures 4A and 4C). Instead, a comprehensive set of genes
required for protein transport through the endomembrane sys-
tem revealed similar metabolic defects. This included retrograde
trafficking from endosome to Golgi and Golgi to ER, the multive-
sicular body (MVB) pathway, the machinery essential for vesicle
fusion (homotypic fusion and vacuole protein sorting (HOPS)/
CORVET complexes), and subunits of the vacuolar ATPase (Fig-
ures 4D and 4E). 69.2% and 61.3% of mutants associated with
Golgi to ER and endosome to Golgi transport (GO terms) showed
altered amino acid levels. In contrast, mutants in ER to Golgi and
Golgi to endosome transport, which are also not sensitive to
TORC1 inhibition (Thomas et al., 2014), were underrepresented
(Figure 4F). The closest resemblance to TORC1 inhibition was
obtained for the endosomal transport processes, in particular
when interrupting the Golgi-associated retrograde proteinCell 167, 553–565, October 6, 2016 557
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Figure 4. Amino Acid Signatures of TORC1 Inhibition during Exponential Growth Reflect an Interruption of Vesicle-Mediated Transport
(A) Metabolic signatures, co-clustered on the genome scale, associate rapamycin with the TORC1 complex and cycloheximide with ribosome biogenesis (see
Data S1 for the full map).
(B) The deletion of the TORC1 subunit TCO89 and TORC1 upstream regulators creates a metabolic signature matching rapamycin treatment; the deletion of
TORC1 inhibitors mirrors this concentration profile.
(C) Neither individual perturbation of TORC1 downstream effectors nor translation inhibition can explain the amino acid profile of TORC1 inhibition.
(D) Perturbation of the vesicle-mediated transport machinery at the endosome triggers a metabolic signature that matches TORC1 inhibition (green, average
profile of the TORC1 network).
(E) Scheme: vesicle-mediated protein transport pathways in the endomembrane system.
(F) Vesicle-mediated transport and the endomembrane system are crucial for maintaining amino acid homeostasis under exponential growth. Golgi to ER
transport has the highest relative response rate, followed by endosome to Golgi and endosome to vacuole transport. *p < 0.05; **p < 0.01; ***p < 0.001 (GSEA).
Abbreviations: EE, early endosome; MVB, multivesicular body pathway/late endosome; CVT, cytoplasm to vacuole trafficking; MIA, micro-autophagy; MAA,
macroautophagy; END, endocytosis; SEC, secretory vesicles; pt, partial deletion of gene.(GARP) complex, the retromer complex, and the sorting nexins
Snx4p and Snx41p (Figure 4D). Indeed, a TORC1-like signature
was triggered by all subcomplexes of the ESCRT apparatus and
its associated genes,DOA1 andDOA4. Furthermore, the TORC1
signature was shared upon deletion of the SNARE protein
Pep12p and the tethering factor Vps3p (Figure 4D). Finally,
despite slow growth, yeast lacking the clathrin light or heavy
chain genes (CLC1, CHC1) and yeast with a deficiency in the in-
tegral membrane lipids phosphatidylinositol 3-phosphate (PI3P)
and phosphatidylinositol 3,5-bisphosphate (PI(3,5)P2) by dele-
tion of VPS15 and FAB1, respectively, had matching profiles.
Overall, similar but quantitatively stronger changes were ob-
tained upon perturbation of the vesicle fusion machinery located
at the vacuole. This includes the HOPS complex, the t-SNARES
VAM3 and VAM7, and the vacuolar ATPase, of which our screen558 Cell 167, 553–565, October 6, 2016contained the regulatory components RAV1 and RAV2 and the
assembly factors PRK1 and VPH1. Furthermore, despite
excluding mutants for the V0 and V1 ATPase subunits and as-
sembly factors VPH2 and VMA21 from the genome-scale anal-
ysis due to strong growth defects, their profiles matched too
(Figure 4D). However, other processes across the genome did
not match these metabolic changes, implying that TORC1 func-
tion in exponentially growing cells connects to amino acid meta-
bolism via its role in the endomembrane transport system.
Metabolic Signatures Provide Orthogonal Functional-
Genomic Information
Metabolic signatures were sufficiently specific to genomically
cluster rapamycin to TORC1 and cycloheximide to translation
(Figure 4A) and hence imply a potential for identifying drug
targets and for functional annotation. The 4,678 metabolic
profiles were analyzed by robust consensus clustering (Monti
et al., 2003) using pairwise Mahalanobis distances and an
optimal cluster division calculated by adaptive branch pruning
(Langfelder et al., 2008). 75%of 280 obtained clusters (Figure 6A;
Table S1) were statistically enriched for GO (74%) or Kyoto Ency-
clopedia of Genes and Genomes (KEGG) (17%) functional terms
(Figure S4A). Propagating the cluster enrichment to itsmembers,
3,923 genes (83%) of gene deletions strains were associated
with functional terms. The clustering was efficient for genes
possessing both strong and weak amino acid signatures and is
hence not a function of the strength of metabolic impact, as
long as metabolic changes are detectable (Data S1).
As no ‘‘gold standard’’ dataset for evaluating metabolism-
driven gene annotation is available, we tested our dataset in
respect to protein complexes (Complex Enrichment Analysis
Tool [COMPLEAT]; Vinayagam et al., 2013), low-throughput ge-
netic and physical protein-protein interactions (Chatr-Aryamontri
et al., 2015), and curated gene ontologies (Myers et al., 2006).
The gene pairs were ranked by their probability to co-cluster
(consensus index) and subjected to a precision-recall analysis.
At a true-positive recall of 1,000 gene pairs, we obtained a pre-
cision, the ratio of true positives (TP) over true and false positives
(TP + FP), that was 4.8 times, 4 times, and 2 times higher than by
random expectation (10%), respectively (Figure 5A). Restricting
gene pairs to those showing significant concentration changes,
we recover 5,000 gene pairs with a precision 2.2 times better
than at random. Keeping in mind that metabolic profiles asso-
ciate genes according to phenotype and are by nature different
in terms of physical interactions, this result revealed a substantial
recall of existing knowledge. To illustrate the potential of the
approach, we cluster the 127 non-essential ribosomal genes
and obtain a correct subunit allocation (Figure 5B).
We then questioned to which extent functional metabolomics
would provide new information compared to existing physical,
and genetic interaction networks. We compared a graph con-
structed from the metabolic clusters, to the comprehensive
sets of functional genomic networks as stored in Search
Tool for the Retrieval of Interacting Genes/Proteins (STRING)
(Szklarczyk et al., 2015) and YeastNet (Kim et al., 2014) data-
bases. We found that metabolic signatures provide highly
orthogonal information (Figure 5C). The maximum overlap in
connectivity was 0.06 and was obtained upon combining all
STRING networks (Figure 5C). The relationship between meta-
bolic-signature-based association and the preexisting functional
genomic data is illustrated for the lipoic acid (LA) biosynthetic
pathway, which has recently been solved by classic biochemical
experiments (Cronan, 2016). The metabolic pathway, plus its
association with the PDH complex that requires lipoic acid as
cofactor, are comprehensively captured over their metabolomic
signature (Figures 5D and 5E; Table S3). The other datasets
fully capture the pyruvate dehydrogenase (PDH) complex, but
despite being much more comprehensive, they largely failed to
connect it to the LA pathway (Figures 5E and 5F).
Next, we illustrate ten unrelated cellular processes captured
over their metabolic signature and compare the associations
with physical and genetic interaction data (Figure 6B). Functional
metabolomics captured transcriptional regulation via chromatin,including histone methylation (cluster 129), deacetylation (clus-
ters 70 and 134), and nucleosome remodeling (clusters 156
and 222), organellar biology (cluster 105, peroxisome; cluster
54, Golgi; cluster 106, the ESCRTmachinery), tRNA biosynthesis
andmodification (clusters 36 and 82), double-strand break repair
(cluster 124), respiratory metabolism (cluster 20), and the barely
understood phenotype of oxidant-induced cell-cycle arrest
(OCA2-5 genes, cluster 212). Genes within these clusters are
assembled in a fully connected graph (graph density of 1) for a
comparison to the existing networks. We reveal a coverage of
10%–100% of the metabolically derived connections, which il-
lustrates the robustness of the approach aswell as its orthogonal
information content (Figure 6B).
We experimentally validated cluster 135, characterized by
high levels of alanine, aspartate, glutamate, and proline and
reduced levels of histidine (Figures 6C and S5A, cluster 135;
Table S3). The cluster contains genes important both for vesicle
fusion at the vacuole and for autophagy, i.e., the class B vpsmu-
tants Dvps5, Dvps17, Dvps41, Dvam3, Dvam7, the Rab GTPase
Ypt7p and its heterodimeric guanine nucleotide exchange factor
(Mon1p/Ccz1p) (Figure 6C, left), and three unrelated deletion
strains (mch5D, opt2D, and tef4D) (Figure 6C, middle). We
confirmed the metabolic profile in replicate measurements (Fig-
ure S5A), increased rapamycin sensitivity (Figure 6C, left bot-
tom), and, except for Dtef4, detected a characteristic phenotype
of autophagy deficiency, the impaired cleavage of GFP-Atg8
upon nitrogen starvation (Suzuki et al., 2001) (Figure 6C, right).
Further, fluorescence microscopy showed abnormal vacuolar
morphology (Figure 6C, right bottom) and a diminished release
of GFP-Atg8 to the vacuolar lumen (Figure 6C, bottom). Other
high-throughput studies strengthen these associations (Fig-
ure 6C, top left); Dmch5, Dopt2, and Dtef4 genes have been
classified as rapamycin sensitive (Parsons et al., 2004; Xie
et al., 2005) and were scored to possess vacuolar morphological
defects (Michaillat and Mayer, 2013). Dmch5 and Dopt2 dele-
tion strains have further been associated with Dmon1, Dccz1,
Dvam7, andDvps41 in a screen for H2S accumulation (Sambade
et al., 2005), whileMCH5 and OPT2 transcripts change dramat-
ically upon a shift from a rich to poor nitrogen source (both 10-
fold change) that is impaired upon perturbation of the protein
sorting machinery (Dvps45) (Kingsbury and Cardenas, 2016).
DISCUSSION
Despite the importance of amino acids as a key component of
metabolism is universally accepted, a comprehensive picture
of the genetic network behind their regulation is still missing.
Indeed, metabolite concentrations and metabolic fluxes can so
far not be calculated from transcriptome and proteome data or
from other molecular networks, including protein-protein and
genetic interaction data. The metabolome hence provides an
orthogonal set of information compared to the other molecular
levels (Allen et al., 2003). We here present a genome-scale quan-
titative metabolic map created by precisely measuring amino
acid concentration changes upon deletion of the nonessential
Saccharomyces coding genome. As a key requirement to map
the interactions between genome and biosynthetic metabolism,
we study prototrophic cells grown to exponential phase and inCell 167, 553–565, October 6, 2016 559
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Figure 5. Amino Acid Signatures Are Informative about Gene Function and Provide Orthogonal Information to Other Molecular Networks
(A) Precision-recall analysis evaluating metabolite profiles in comparison to curated protein complexes, low-throughput genetic and physical protein-protein
interactions, and GO terms. The different gold standards are color coded and the set of metabolic signatures distinguished by transparency; the dashed line
corresponds to the random classifier.
(B) Metabolic signatures reflect structural proximity of the 127 non-essential ribosomal proteins, mapped to the ribosomal structure (PDB: 4V8Y) (Ferna´ndez et al.,
2013).
(C) Orthogonality of functional metabolomics to other molecular data. Metabolic signatures were assembled in a phenotypic association network and compared
to STRING and YeastNet functional genomic datasets. y axis is the overlap of edges between the genes (nodes) present in the compared networks, whereas the
x axis is the ratio of edges, comparing the STRING or YeastNet, to themetabolic clustering. Circle size indicates the number of genes compared. Abbreviations as
in YeastNet (given in full in Figure S4C). Metabolic signatures provide highly orthogonal information, and the best agreement is obtained upon combining all data
as contained in STRING (C(S)).
(D) Metabolic signatures provide orthogonal information to existing molecular networks, as exemplified by the lipoic acid (LA) biosynthesis pathway, which
provides the cofactor for the pyruvate dehydrogenase (PDH) complex. Scheme of the pathway is shown.
(E) Association of metabolic signatures (LA and PDH cluster), in comparison to yeast genetic and physical interaction networks as accessed through YeastNet.
A majority of the associations among the LA biosynthetic genes are obtained only over the metabolic signature.
(F) Summarizing the information content of all molecular networks (E), except metabolic signature, in comparison to the association obtained over the
metabolic signature (full matrix). When combined, genetic and physical interaction networks capture the PDH complex but provide only partial coverage of the
LA pathway.minimal-nutrient medium. We focus on amino acids, as they
are responsible for a major fraction of the metabolic flux in expo-
nentially growing cells, represent a large proportion of the total
metabolite mass, and, while precisely regulated, converge a
large fraction of biosynthetic metabolism. Furthermore, we profit
from the chemical properties of amino acids that enabled us to
develop precise, fast, and reliable analytics to capture large
and small concentration changes on the genomic scale.
We found that the yeast amino acidmetabolome is sensitive to
at least 1,519 gene deletions and that a majority of them specif-560 Cell 167, 553–565, October 6, 2016ically impact the metabolome. Obtaining specific metabolic sig-
natures on the genomic scale contradicts assumptions that
global physiological factors such as growth rate or external
nutrient supply would be the prime regulators of metabolism;
each amino acid concentration can be independently affected
by a gene deletion, but we find that some amino acids that share
functional or biosynthetic properties robustly correlate on the
genomic scale. In total, more than 1,000 non-essential genes
are found to participate in genome-metabolism interaction,
and their joint action creates the amino acid signature of a cell.
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Figure 6. Association of Gene Function through Functional Metabolomics
(A)Metabolic signatures divide the genome according to function. The full heatmap detailing the hierarchical cluster analyses spans over 280 clusters (Data S1; 47
pages); 75% of the clusters, spanning over 3,923 gene deletions, are significantly enriched for functional GO and KEGG terms.
(B) Gene function in biological processes is captured by metabolic signature similarity (ten examples are given here; all clusters in Data S1 and Table S3). Yeast
genetic and physical interaction networks (BIOGRID) support these clusters to different extents (coverage of 42%–100% of nodes and 10%–100% of edges;
graph density, pie charts).
(C) Phenotypes of gene deletion strains (top left) confirm new associations as in cluster 135, representing vesicle fusion at the vacuole (top middle). The gene-
deletion strains are characterized by autophagy deficiency upon nitrogen starvation, visualized by a GFP-ATG8 cleavage deficiency (top right), sensitivity to
rapamycin as expressed in a dose-response curve (bottom left) (mean ± SD, n = 4), and abnormal vacuolar morphology upon 6-hr nitrogen starvation (bottom
right). *p < 0.05; **p < 0.01; ***p < 0.001 (Student’s t test).Amajority of these genes are however not direct ‘‘metabolic reg-
ulators’’ in a sense that they would be transcription factors,
signaling kinases, or metabolic enzymes. Instead, they are ‘‘indi-rect’’ participants in metabolism and a part of the protein trans-
lation machinery, organelles, and transport pathways or operate
at the chromatin level to enable gene expression. Of note, theCell 167, 553–565, October 6, 2016 561
latter were highly enriched for metabolic alterations, but not
gene-specific transcription factors, which created much smaller
effects. Potentially, an evolutionary explanation for this finding
exists. Metabolism is one of the oldest cellular systems that
require regulation (Luisi, 2014). The general gene expressionma-
chinery, older than gene-specific transcription factors, could
have evolved to regulate metabolism. Consistently, we find
that the sophisticated transcriptional systems that adapt meta-
bolism in stress situations, like GCN4, the SPS sensor, or the ni-
trogen catabolite repression systems, are largely dispensable for
exponential metabolism. This includes tor1D, whose metabolic
signature is strong under nitrogen starvation (Zhang et al.,
2011) but was weak and not significant in our growth conditions
(Figure 4B). However, TORC1 function is not in essence bound to
the presence of the TOR1 kinase, as its paralog, TOR2, can
assume its function (Helliwell et al., 1994). Indeed, we found a
strong metabolic impact of the kinase network that centers on
the TORC1 complex. Deletion of TORC1 upstream activators
and cells treated with rapamycin share a similar metabolic
signature. Our genome-scale data allowed us to map the
responsible downstream processes. We did obtain a genome-
wide unique match in the vesicle-mediated transport machinery.
Previous studies support a function of TORC1 in the regulation
of vesicle-mediated transport. Sec13p and Vam6p, which
are required for endomembrane dynamics, also play a role in
TORC1 activation (Binda et al., 2009; Panchaud et al., 2013).
Furthermore, the small GTPases Vps21p, Ypt1p, Ypt6p, and
Ypt7p regulate membrane fusion events via HOPS, CORVET,
and GARP, and their deletion causes rapamycin sensitivity and
reduced TORC1 activity (Bridges et al., 2012; Thomas et al.,
2014). Together with our study, these results imply that at least
in respect to amino acid metabolism, the prevalent function of
TORC1 in exponentially growing cells is to maintain endomem-
brane transport. It is worth speculating that the connection be-
tween TORC1 and these transport processes is explained by
the importance of amino acid recycling.While protein catabolism
is highly important for amino acid homeostasis during starvation
and in the stationary phase where biomass is maintained, during
exponential cell growth, amino acids are synthesized de novo to
gain biomass. TORC1 could balance between these metabolic
states.
We exploit the unanticipated precision of metabolic signatures
for functional annotation on the genomic scale. Amino acid
signatures were sufficiently specific to assign rapamycin to
TORC1, cycloheximide to translation (Figure 4A), and to group
the genome in 280 functional-metabolic clusters. The cluster
associations contain orthogonal information in respect to phys-
ical, molecular, and genetic interaction networks. Assessing an
understudied functional level, functional metabolomics is hence
particularly informative about genes that were not annotated
by these canonical approaches. Indeed, the number of poorly
characterized genes is substantial (Botstein and Fink, 2011)
and at present includes up to2,000 yeast open reading frames
(ORFs) (Figures S4A and S4B). Revealing their importance, one-
third of the essential genes in an engineeredminimal genome are
required for unknown reasons (Hutchison et al., 2016). The
amino acid signatures associate functional terms with 56.6%
of the 1,823 barely and uncharacterized Saccharomyces genes562 Cell 167, 553–565, October 6, 2016that were part of our study (Figure S4A). Indicating relevance
for a broad number of species, 823 of these genes could be as-
signed to orthology groups using eggNOG 4.5 (Huerta-Cepas
et al., 2016), of which 440 contain human homologs.
It was unanticipated to achieve such a high degree of
functional information solely through the amino acid me-
tabolome. However, one needs to keep in mind that amino
acids are among the most important and most abundant
metabolites and, as a consequence, are tightly regulated,
and by originating from different branches of carbon meta-
bolism, they converge on a broad spectrum of metabolic ac-
tivity. The absolute quantitative nature of our data allows a
combination with future studies to address other metabolites,
metabolic fluxes, or different growth conditions. Such multio-
mic attempts will further increase the precision of gene anno-
tation. Indeed, despite assigning >1,500 genes to metabolism,
our study is far from providing a complete picture of genome-
metabolome interactions, as experiments that depend on
exponential growth conditions fail to capture essential, con-
dition-, and stress-responsive genes. Important orthogonal
information would be provided by flux measurements, as a
change in amino acid concentrations will not always reflect
changes in flux, and vice versa. Finally, as in other func-
tional-genomics studies, ours depends on the quality of the
genetic library and the natural stability of the eukaryotic
genome. Indeed, many genetic modifications trigger compen-
satory or secondary mutations, which have to be taken
into account when interpreting individual phenotypes (Teng
et al., 2013).
In conclusion, we present a precise, genome-spanning
functional-metabolomic map in budding yeast. Converging a
major fraction of cellular metabolism, and by being precisely
captured by targeted analytics, the amino acid metabolome
provides system-scale insights into the regulation and ho-
meostasis of biosynthetic metabolism in the exponentially
growing cell. The biosynthetic metabolome is sensitive to the
concerted action of more than 1,500 genes. In most instances,
their deletion creates highly specific concentration signa-
tures that attribute dominating roles of the metabolism-reg-
ulatory network to gene regulation at the chromatin level, pro-
tein translation, and the protein transport machinery. The
genomic-scale view of metabolism connects the regulatory
networks with their main effectors, as exemplified by TORC1,
whose main metabolic impact under exponential growth is
associated with vesicle-mediated transport. Functional me-
tabolomics is thus revealed to possesses a high potential for
functional gene annotation, as exemplified by assigning 127
non-essential proteins to the correct structural element of
the ribosome, reconstructing the pathway of LA biosynthesis
and its association with the pyruvate dehydrogenase complex.
By providing orthogonal information in respect to existing
physical and genetic interaction networks, these phenotype-
based associations are particularly effective for annotating
genes that have so far remained uncharacterized. As a result,
more than half of the so far poorly characterized yeast genes,
many of which possess orthologs in other species (up to
humans), receive a putative functional association over their
metabolic signature.
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Gibney et al., 2013 N/A
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Recombinant DNA
pHLUM Mu¨lleder et al., 2012 Addgene ID: 40276
pRS316-GFP-AUT7 (expresses GFP-Atg8) Suzuki et al., 2001 N/A
pHLM This study Addgene ID: 64168
Software and Algorithms
R: A Language for Data Analysis and Graphics,
version 2.1
http://www.r-project.org N/A
grofit http://cran.r-project.org/web/
packages/grofit/index.html
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EXPERIMENTAL MODEL AND SUBJECT DETAILS
Yeast
Batch assignments: The 4913 deletion strains were arrayed on 62 96-well plates, joining plates 50 and 73 as well as plates 71 and F
(Table S4), in comparison to the original arrangement of the prototrophic library (Mu¨lleder et al., 2012). The original MATa deletion
collection contains plates, which are enriched for deletion mutants showing growth defects: plates 50, 51 and 70 - 75 (Winzeler
et al., 1999). Plates A-G from the prototrophic library creation add to these plates as they contain strains, which did not easily trans-
form with the prototrophy conferring plasmid (Mu¨lleder et al., 2012). To avoid any influence of the heterogeneous assembly of
the strains, we assigned the plates to 11 batches distributing the plates 50-51, 70-75 and A-G evenly over the course of analysis
(Table S4).
The strains were transferred to synthetic minimal (SM) agar medium (6.7 g/l yeast nitrogen base without amino acids (Y0626,
SIGMA), 2% glucose, 2% agar) using a robot (Rotor, Singer instruments) and incubated for 48 hr at 30C. These spots were used
for the inoculation of cultures in liquid SM (96-well plate, 150 ml/well) and were grown for 24 hr, diluted 1:20 and finally cultured in
96-deep well plates with 1.685 ml SM medium and one 2 mm borosilicate bead/well for enhanced stirring. These plates were incu-
bated for 8 hr in a Heidolph Titramax 1000 (900 rpm, 30C).
Samples for verification experiments (Figure S5) were generated similarly in multi-well format. For chemical perturbation experi-
ments (Figure S3), cells were inoculated in 3 ml SM medium and grown ON. Cultures were inoculated at an OD600 of 0.15 in 10 ml
SMmedium containing rapamycin at 50 nM or cycloheximide at 890 nM and were incubated for 8 hr before an aliquot corresponding
to 1.5 OD600 was collected. Starvation medium, SD (–N), was prepared with 1.7 g/l yeast nitrogen base without amino acids and
ammonium sulfate (Y1251 SIGMA) and 2% glucose.
METHOD DETAILS
Quantification of Amino Acids in High Throughput
Strains from the same batch were cultivated and their metabolites extracted on the same day and analyzed together by LC-MS/MS.
Before analysis by LC-MS/MS the order of samples within the same batch was randomized. During analysis a quality control sample
(QC) was assessed every 24 samples and in total 237 times. The QC was prepared by joining the extracts of the first batch including
metabolites of 351 deletion strains. Eventually, it was used to monitor analytical performance and to calculate the technical variation
(Figure S1B). In a second screening round, the 479 deletion strains that showed lowest metabolite concentrations were arranged on
6 additional plates and the analysis was repeated (batch 12).Cell 167, 553–565.e1–e6, October 6, 2016 e2
Metabolite Extraction
Cells were collected by centrifugation, the medium discarded and the samples extracted with 200 ml 80C hot ethanol containing
isotope labeled amino acid standards (50 mg/ml algae hydrolysate amino acid mixture (U-13C, 97%–99%; U-15N, 97%–99%; Cam-
bridge Isotope Laboratories CNLM-452-0.5) that were used for quality control and to detect outliers. Residual medium resulted in a
final ethanol concentration of approximately 80%. The extract was heated for 2 min at 80C, vigorously mixed on a vortex mixer and
incubated for further 2 min at 80C. The extract was cleared from debris by centrifugation and stored at 80C. Before analysis,
extracts were thawed and sonicated for 5 min. For chemical perturbation experiments, the supernatant was removed completely
and the cells extracted with 200 ml 80% ethanol.
Analysis by LC-MS/MS
Amino acids were separated by hydrophilic interaction liquid chromatography (HILIC) using an ACQUITY UPLC BEH amide column
(130A˚, 1.7 mm, 2.1 mm X 100 mm) on a liquid chromatography (Agilent 1290 Infinity) and tandem mass spectrometry (Agilent 6460)
system. The method separates the amino acids by chromatographic means and/or mass transition (Figure 1A), is specific for intra-
cellular amino acids (Figure S1B), and fully covers the dynamic range of physiological amino acid concentrations (Figure S1C)
(Mu¨lleder et al., 2016).
Buffer A was composed of 50:50 acetonitrile/water (Greyhound Bio-012041, Greyhound 23214125), 10 mM ammonium
formate (Fluka 14266), 0.176% formic acid (Fluka O6454) and buffer B of 95:5:5 acetonitrile/methanol/water (Greyhound
BIO-13684102), 10 mM ammonium formate, 0.176% formic acid. The gradient elution was performed at a constant flow
rate of 0.9 ml/min. Starting conditions were 85% buffer B, after 0.7 min the concentration of buffer B was decreased gradually
to 5% until 2.55 min and kept for further 0.05 min before returning to initial conditions. The column was then equilibrated
resulting in a total runtime of 3.25 min. Compounds were identified by matching retention time and fragmentation (MS2) with
commercially obtained standards (LAA21, Sigma-Aldrich). Signals for free amino acids were then acquired in dynamic SRM
mode in Masshunter software. The m/z transition and retention times are listed in Table S5.
Rapamycin Sensitivity Assay
Strains were inoculated at 0.1 OD600 at 11 rapamycin concentrations from 7 to 1000 nM (n = 4) in a 384 multi well plate (70 ml/well) in
SMmedium and growth wasmonitored for 48 hr. The maximum specific growth rate was determined with R package grofit and used
to determine the EC50 value in a dose response curve (Figure 6C).
Visualization of Proteolytic Cleavage of GFP-Atg8 by Western Blot
Prototrophic strains expressing GFP-Atg8 were collected in SMmedium during exponential growth, and inoculated in nitrogen-star-
vation medium SD (–N) for 6 hr at 30C. Aliquots corresponding to 5 OD600 were collected, washed with 10% TCA and ice-cold
acetone and proteins mechanically extracted in MURB buffer using a FastPrep instrument and acid-washed glass beads. The sam-
ples were heated 10 min at 70C, an aliquot corresponding to 0.3 OD600 was loaded and GFP and GFP-Atg8 were visualized with
chemiluminescence on a nitrocellulose membrane using rabbit polyclonal to GFP (Abcam, ab290) and goat anti-rabbit IgG-HRP,
(Santa Cruz Biotechnology, sc-2004) antibodies.
Fluorescence Microscopy
Cells were collected during exponential growth in SMmedium, starved for 6 hr in SD (–N) medium andmounted on 1% agarose pads
prepared with SD (–N)medium. Imageswere acquired on anOlympus IX81wide fieldmicroscope (Deltavision, GEHealthcare) equip-
ped with a 1003 /1.4 numerical aperture oil immersion lens (UPLSApo Oil, Olympus) and a CoolSNAP HQ2 CCD camera (Figure 6C).
The filter set used for GFP was Ex 490/20 Em 528/38. Image stacks were collected in 0.2 mm increments and for deconvolution the
ratio conservative algorithm was used in Deltavision Softworx software. Five to ten slices of one image Z-stack were selected, back-
ground noise calculated and removed, and the slices projected with the ‘‘sum slices’’ method and brightness and contrast adjusted in
ImageJ.
QUANTIFICATION AND STATISTICAL ANALYSIS
All statistical analysis was performed in R (http://www.r-project.org).
Quantification of Free Amino Acids by External Calibration
To reduce effects of instrumental drift we used a ‘‘bracketing’’ method, measuring every 24 samples a set of standards. External
calibration was then performed including both sets of standards, before and after the set of samples. For each amino
acid we chose either a linear regression or linear regression after log transformation (power-law fit) (Table S5). Analytical stan-
dards that were more than 4 times higher or lower in concentration than the highest or lowest concentrated sample were
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QUALITY CONTROL AND DATA CORRECTION
Strain Quality Management
Wewere able to obtain 4678 strain specific free amino acid profiles, were not however able to do so for another 259 deletion strains,
mostly for the reasons of lethality on minimal medium ( = auxotrophy). 208 strains did not show any growth or highly impaired growth
in the absence of amino acid supplementation, as defined by the following criteria: we first determined the number of average cell
divisions by random selection of 175 strains and determination of their optical density (OD595). The median OD595 after 7.5 hr of
cultivation was 1.46 and the number of cell divisions 2.79. We next calculated a probabilistic dilution factor (probabilistic quotient
normalization, PQN) for each deletion strain. A dilution factor of 0.25, corresponding to approximately 0.8 cell division, was chosen
as a cutoff criterion; all strains below this threshold were defined as slow growers.
Additionally, we excluded the complemented deletion strains his3D::kanMX4 andmet17D::kanMX4, 3 deletions strains that were
identified to be cross-contaminated (aco1D, lip5D and mtc1D), and 24 strains with outdated ORF annotations (SGD).
Batch Normalization and Correction for Sample Dilution
For batch normalization we adapted the approach from the MIPHENO normalization workflow (Bell et al., 2012), where a scaling fac-
tor is calculated to bring the batch means to a global mean. First we calculated the overall mean considering all samples. Next, and in
contrast to the previously described workflow, we compensated for dilution effects within batches by PQN before determining the
mean for each batch. By dividing each sample by its respective batchmean andmultiplying by the overall mean, we bring each batch
to the same level. Finally, we corrected for sample dilution using PQN normalization.
Robust Estimation of Summary Statistics and Identification of Altered Metabolic Profiles
The unperturbed value for each metabolite is determined with robust statistical methods by excluding the contribution of few, signif-
icantly changing metabolites. We used the Minimum Covariance Determinant (MCD) estimator to obtain robust values for mean,
standard deviation, correlation and covariance for each amino acid (Figures 1 and 2A). The robustly estimated average amino
acid concentration of all analyzed strains, was identical to that of the wild-type background strain (Figure S1F). With the robust
mean and covariance matrix we calculated Mahalanobis distances as robust multivariate metric for dissimilarity from the unaffected
amino acid profile. p-values for the amino acid concentrations were calculated using the Z-test statistic. A p-value for the change in
the overall amino acid profile was calculated from the Mahalanobis distance using the c2 statistic. All p-values were adjusted for
multiple testing with the Benjamini & Hochberg method (BH) to identify significantly altered metabolic profiles (Figure 1) (Table S3).
Estimation of Intracellular Concentration
To estimate the intracellular concentration of free amino acids (Figures 1B and 1F) we determined the median OD595 of the analyzed
samples (1.46), the approximate extraction volume (200 ml) and used the values for cells/OD595 (3.2*10
7) and cell volume (45.54 fL) for
the strain BY4741 in synthetic minimal medium.
Quality Control and Completeness
Eventually, we completed a metabolic profile for 4678 yeast deletion strains, capturing 99% of the gene-knockouts that do not
possess a strong growth defect in minimal medium, corresponding to 95% of all viable strains (Figure 1A, Table S3). Cysteine
was omitted from further analysis, due to its property of being quickly oxidized upon cell lysis and hence giving imprecise results.
The precision of the remaining amino acid quantifications is reflected in an R2 greater 0.99 in 95% of 4518 calibration curves,
revealing low technical variability (Figures S1D and S1E). To assess the quality of the used prototrophic library used (Mu¨lleder
et al., 2012) we have compared the results of selected strains isolated from an analogous genomic library (Gibney et al., 2013)
and obtained comparable metabolic footprints (Figures S5B and S5C).
CLUSTER AND ENRICHMENT ANALYSIS
Consensus Clustering
Consensus clustering was based on hierarchical clustering using pairwise Mahalanobis distance (Monti et al., 2003) and Ward’s
method as agglomeration method. Before calculating the consensus metrics, we perturbed the data by randomly removing 0%–
20% of amino acid profiles and cut the dendrogram at 8 different depths with the dynamicTreeCut package in R, and repeated
this in total 500 times. The obtained consensus matrix was then subtracted from 1 and used as the distance metric for hierarchical
cluster analysis (Ward’s method). 280 clusters were obtained with following settings: minClusterSize = 2, respectSmallClusters = T,
deepSplit = 4.
Mapping the Response to Rapamycin or Cycloheximide to the Profiles of the Deletion Collection
Yeast was treated with 50 nM rapamycin or 890 nM cycloheximide in exponentially growing culture in minimal medium, and an amino
acid concentration profile recorded. To enable a comparison of the small scale perturbation and high-throughput screening exper-
iments, the amino acid concentrations of the small scale experiments were standardized by first subtracting the values of theCell 167, 553–565.e1–e6, October 6, 2016 e4
untreated isogenic parental strain and then by dividing by the robust standard deviation (MCD) determined for the deletion collection.
The 4678 deletion strains together with the rapamycin or cycloheximide treated wt were then hierarchically clustered (pairwise Ma-
halanobis distance using the robust covariance matrix (MCD) determined for the deletion collection, Ward’s method) (Figure 4A).
ENRICHMENT ANALYSIS
Gene set enrichment analysis (GSEA) (Figures 2B and 3D) was performed with piano (Va¨remo et al., 2013) and was based on the
c2-test statistic. Enrichment analysis GO categories related to vesicle mediated transport was calculated by hypergeometric testing
(phyper function in R) (Figure 4F).
Enrichment Analysis in Clusters
The list of genes obtained for each of the clusters was tested for enrichment of GO and KEGG annotation in R with the GOstats
package.
ENRICHMENT ANALYSIS IN CLUSTERS FOR EACH OPEN READING FRAME
To improve the predictive value for functional characterization of open reading frames (ORF), we removed the respectively studied
ORF from the cluster and from the background-set of genes in all analyses.
ENRICHMENT ANALYSIS FOR METABOLIC GENE CARDS
Phenotypic descriptions and literature annotations were obtained from SGD on 10.08.2016 and the significance of overrepresenta-
tion calculated using hypergeometric testing. Obtained p-values were corrected with the FDR method from Benjamini & Hochberg
(p.adjust function in R). Enrichment for gene ontology and KEGG categories was calculated in R with the GOstat package
(10.08.2016).
CONSTRUCTION OF A GENE ONTOLOGY MAP
The gene ontology database for Saccharomyces cerevisiae annotates 4678 analyzed genes by 6806 functional terms (Cherry et al.,
2012). This includes direct annotations, or annotations inferred or propagated from children to their parent terms through the GO
graph. Considering only direct gene annotations, we detect an enrichment for 80 GO terms by GSEA (BH adjusted p < 0.05) and illus-
trate them in a network for systematic evaluation. In this gene ontology map GO terms constitute the nodes that are connected by
gene overlap, when two terms share more than 50% of their annotated genes. Edges are drawn for nodes that have a shortest path
length of 1 or 2 and redundant edges are removed. We chose a force-directed graph layout (Fruchterman–Reingold algorithm) and
identified clusters based on edge betweenness (igraph package in R).
EVALUATION OF FUNCTIONAL METABOLOMICS COMPARED TO AVAILABLE DATASETS
Precision Recall Analysis
The gold standard dataset used for gene ontology terms contained only manually curated annotations (Myers et al., 2006). The true
positive (TP) sets for protein complexes are based on the COMPLEAT database (Vinayagam et al., 2013) and for physical and genetic
interaction we used the low-throughput annotation in the BIOGRID database (Chatr-Aryamontri et al., 2015). A true negative gene set
(TN) for protein complexes was generated from proteins belonging to distinct complexes and being annotated to different subcellular
locations (gene ontology), excluding the cytosol, and for physical and genetic interaction by randomly selecting genes of non-inter-
action pairs (BIOGRID). Before analyzing the predictive power of amino acid profile similarity in the three datasets, the TN sets were
reduced to 9 times the size of the TP datasets to fix the precision of a random classifier at 10%.
Orthogonality of Metabolic Signatures
To compare functional annotations of amino acid profiles with other known functional networks, each of the 280 clusters for amino
acid profile similarity was considered as a fully connected graph that resulted in a network with 4678 nodes and 61429 edges. We
downloaded multiple yeast functional annotation networks from STRING v10 (http://string-db.org/) (Szklarczyk et al., 2015) and
YeasNet v.3 (http://www.inetbio.org/yeastnet/) (Kim et al., 2014) resources and compared whether edges based on amino acid
profile similarity were found in any known functional network (Figures 5C and S4C).
DATA RETRIEVED FROM PRIMARY LITERATURE OR DATABASES
Curated genetic information, literature and phenotype annotation was collected from the Saccharomyces Genome Database (SGD)
(Cherry et al., 2012). A list of transcriptional regulators was compiled from the overlap of the YEASTRACT and YeTFaSCo databasese5 Cell 167, 553–565.e1–e6, October 6, 2016
(de Boer and Hughes, 2012; Teixeira et al., 2014), a list of kinases and phosphatases was obtained from the Yeast Kinase and Phos-
phatase Interactome (KPI) Resource (Breitkreutz et al., 2010). We obtained gene sets for following regulatory pathways: unfolded
protein response (UPR) (Travers et al., 2000), nitrogen catabolite repression (NCR) (Godard et al., 2007), general amino acid control
(GAAC) (Moxley et al., 2009), TOR network (Fournier et al., 2010), the SPS-sensing pathway (Eckert-Boulet et al., 2004) and a list of
genes of amino acid metabolism (Figure 3D) and vesicle mediated transport (Figure 4F) from Saccharomyces cerevisiae gene
ontology. The Cryo-EM structure of the 80S-eIF5B-Met-itRNAMet eukaryotic translation initiation complex (PDB: 4V8Y) (Ferna´ndez
et al., 2013) was obtained from RCSB Protein Data Bank and subunits colored according to their amino acid profile, related to
Figure 5B.
DATA AND SOFTWARE AVAILABILITY
The complete dataset is provided in Table S3 and is further available through Metabolights database (http://www.ebi.ac.uk/
metabolights/) and Mendeley Data (http://dx.doi.org/10.17632/bnzdhd6c).
Metabolic Gene Cards
Tomake themetabolism-driven associations broadly accessible, we have created a ‘metabolic gene card’ for each of the 4678 genes
studied. This gene card lists the functional associations each gene receives over its metabolic signatures, and depicts the molecular
network it participates in. The short description for each open reading frames was obtained from SGD. Calculation and illustration of
the perturbation on the amino acid concentration and identification of deletion strains with similar metabolic profile was performed as
described above. The gene cards are accessible at http://ralser.sysbiol.cam.ac.uk/metabogenecards/ and deposited in Mendeley
Data (http://dx.doi.org/10.17632/bnzdhd6c), and linked with the Saccharomyces Genome Database (SGD).Cell 167, 553–565.e1–e6, October 6, 2016 e6
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Figure S1. Properties of the Genome-Scale Metabolic Map of Amino Acid Metabolism, Related to Figure 1
(A) Strains inviable on SMmedium are frequently deficient genes in biosynthetic metabolism and auxotrophs. The 10 quantitatively most enriched Gene Ontology
(GO) biological process (Slim terms) are shown.
(B) Extracellular amino acids are diluted by the protocol used, and do not interfere with reported quantities. A representative sample (n = 3) was grown to OD600 of
1.5, the cells were collected and the amino acid concentration determined after extraction with boiling ethanol for both cell pellet with residual medium (extract)
and the supernatant containing only the extracellular metabolites (extracellular); line: average, ribbon: SD; red: blank measurement (no yeast present).
(C) Linearity over the dynamic range of the amino acid metabolome. An analytical standard mix was prepared at 6 concentrations to cover the full dynamic range
of physiological amino acid concentrations. The combined violin- and boxplot illustrate the determined amino acid concentration for the 4678 deletion strains
before normalization; circles refer to the concentration of the standard mix.
(D) Variation of acquired data as relative standard deviation (RSD). Overall variation (technical plus biological) was robustly estimated with the Minimum
Covariance Determinant (MCD), the technical variation was calculated from a repeatedly analyzed quality control sample (n = 237).
(E) Quality of external calibration with ‘‘bracketing’’ showing an R2 value greater 0.99 in 95% of 4518 curves.
(F) The MCD center estimate for the average of all analyzed strains is identical to the WT amino acid profile; shown for the complemented deletion strains
his3D::kanMX4 and met17D::kanMX4.
(G) The relative magnitude of genetic impact of the single gene deletions is independent of the concentration of the respective amino acid.
(H) Strains with a significantly changed amino acid profile are overrepresented in 5% slowest growing and underrepresented in the 5% fastest growing mutants.
(I) A growth specific amino acid profile was not detected for slow or fast growing strains. Amino acid profiles are ordered by hierarchical clustering (Euclidean
distance, Ward’s criterion).
(J) Among slow and fast growing strains we frequently find amino acids concentrated significantly lower and higher than average, confirming that there is no
growth specific change in a certain amino acid.
(K) Growth correlates weakly with amino acid concentrations (Spearman’s rank correlation coefficient).
Growth datasets were obtained from previous systematic studies: dataset 1, growth determined on synthetic minimal medium of a prototrophic derivative of the
deletion collection (VanderSluis et al., 2014); dataset 2, an auxotrophic derivative of the deletion collection tested in a competition assay in minimal dropout
medium (Breslow et al., 2008).
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Figure S2. Identification of Cellular Processes and Components Important for Amino Acid Homeostasis over a Gene Set Enrichment
Analysis, Related to Figures 2B–2E and Table S1
Comprehensive labeling and complete probabilistic amino acid profiles for the directly associated and enriched GO terms among significantly changed deletion
strains.
BP, biological process; MF, molecular function; CC, cellular component.
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Figure S3. Reduced TORC1 Activity Produces a Specific and Informative Amino Acid Profile, Related to Figure 4
The application of sublethal rapamycin concentration (50 nM) generates a strong response on all amino acid concentrations. Alanine, aspartate, asparagine,
glutamate, glutamine, branched chain amino acids and aromatic amino acids were substantially elevatedwhereas glycine, serine and lysinewere greatly reduced
and this response was strikingly similar to a deletion of the TORC1 component TCO89. All strains were grown for 6 hr and collected in exponential phase. Amino
acid concentrations were determined as described for untreated WT and tco89D (n = 3) and for treated WT (n = 6) and are represented as mean ± SD.
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Figure S4. Metabolic Signatures Add New Functional Information to Incompletely Characterized S. cerevisiae Genomes, Related to Figure 5
(A) (top, left panel) Functional enrichment analysis in 280 clusters for GO and KEGG terms. Enrichment was comparable in clusters with at least one significantly
changed amino acid (responsive) or in clusters without (unresponsive), reflecting that small co-occurring amino acid concentration changes reveal functionally
relevant signature (top, middle panel); functional enrichment analysis as described in STARMethods. For 83% of gene deletions strains, a functional association
was predicted. (bottom panel) 39% percent of deletion strains are not well characterized according to our definition (no GO or function or process term asso-
ciated, annotated as ‘uncharacterized’). A functional association is possible for 83% of them.
(B) To quantitatively enumerate the occurrence of so far poorly and uncharacterized genes in budding yeast, we orient on the most comprehensive collection of
functional information in budding yeast, the Saccharomyces genome database, which combines large-scale, small scale, literaturemining and community-driven
approaches (Cherry et al., 2012). Primary literature contains information about ‘‘function, biological role, cellular location, phenotype, regulation, structure, or
disease homologs in other species for the gene or gene product.’’ All literature further incorporates reviews and publications with ‘‘experimental evidence for the
gene or describe homologs in other species, but for which the gene is not the paper’s principal focus.’’ 26.7% of yeast ORFs have so far been analyzed in only
three to zero dedicated studies, 22% of open reading frames in SGD are considered functionally fully uncharacterized according to systematic annotation, while
35.8% lack so far a gene ontology function or process term association. Genes that are annotated as uncharacterized or lack a GO annotation sum up to 1823
(39%) of the strains analyzed in our study.
Orthogonality of functional metabolomics to othermolecular data. Abbreviations are as described in YeastNet resource, for every network links are inferred from a
different source, as following: CC - co-citation of two genes across 46,111 PubMedMedline article abstracts for yeast biology; CX - co-expression pattern of two
genes (based on high-dimensional gene expression data); DC - co-occurrence of protein domains between two coding genes; GN - similar genomic context of
bacterial orthologs of two yeast genes; GT - similar profiles of genetic interaction partner; HT - high-throughput protein-protein interactions; LC - small/medium-
scale protein-protein interactions (collected from protein-protein interaction databases); PG - similar phylogenetic profiles between two yeast genes; TS - 3-D
protein structure of interacting orthologous proteins between two yeast proteins. The rest interaction networks based on evidences collected in STRING
database, i.e., DB(S) - based on pathways from curated databases; NB(S) - interactions inferred from genomic neighbors; CX(S) - interactions inferred using gene
co-expression; CO(S) - gene co-occurrence in phylogenetic trees; TX(S) - interactions based on automated unsupervised text mining when searching for proteins
that are frequently mentioned together; F(S) - genes that are sometimes fused together; C(S) - based on all combined evidences in STRING.
(C) Perturbation of lipoic acid synthesis or the pyruvate dehydrogenase reaction triggers a highly similar amino acid profile and allows to associate a novel gene
function to clustermembers. Clusters 133, 213 and 235 are joined at greater branch height and form a cluster separated from the remaining deletion strain profiles
(Data S1). The deleted ORF
GO, gene ontology; KEGG, Kyoto Encyclopedia of Genes and Genomes; BP, biological process; MF, molecular function.
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Figure S5. Metabolic Signatures and Gene Function Associations, Related to Figure 6
(A) Amino acid concentration levels determined for selected deletion strains required for vesicle fusion at the vacuole (mean ± SD, n = 3).
(B) Confirmation of observed free amino acid levels in two different prototrophic derivatives of the deletion collection: Collection 1 was created by transformation
with a minichromosome carrying the genes HIS3, LEU2, URA3 andMET17 (Mu¨lleder et al., 2012), collection 2 used the synthetic genetic array strategy and the
magic marker (can1D::STE2pr-SpHIS5) resulting in the genotype can1D::STE2pr-SpHIS5 lyp1 his3 ho (Gibney et al., 2013; VanderSluis et al., 2014). Both
collections are derived from the BY4741 deletion collection (Winzeler et al., 1999), have the mating typeMATa and contain a complemented his3 deletion strain
representing the isogenic reference wt strain. (left panel) The amino acid levels of the WT strains (n = 12) are compared. Analysis by linear regression, slope of 1
and an R2 value of 0.955, indicate that there is no difference between the respective profiles.
(C) Verification of the metabolic profile of selected deletion strains described in the main article (mean ± SD, n = 3): fpr1 in Figure 1F, pda1 in Figures 5D and S4C,
and vps41 in Figure 6C. *p < 0.05, **p < 0.01, ***p < 0.001, Student’s t test.
